Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with the rodenticide vacor

Diabetes

Volumn 45, Issue 11, 1996, Pages 1531-1534

  Esposti, Mauro Degli ^a   Ngo, Anna ^a   Myers, Mark A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RODENTICIDE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HIGH ENERGY PHOSPHATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; INTOXICATION; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029909113     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1531     Document Type: Article

References (36)

1. Atkinson MA. Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
2. Ferner RE: Drug-induced diabetes. Bailleres Clin Endocrinot Metab 6:849-866, 1992
3. Hagopian W, Lernmark A: Autoinunune diabetes mellitus. In The Autoimmune Diseases II. Rose NR, Mackay IR, Eds. San Diego, CA, Academic Press, 1982, p. 235-278
4. O'Reilly LA, Cooke A: Animal models for insulin-dependent diabetes mellitus. In The Molecular Biology of Autoimmune Diseases. Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, Eds. Chur, Switzerland, Harwood Academic, 1993, p. 619-625
5. Ganda OP, Rossini AA, Like AA: Studies on streptozotocin diabetes. Diabetes 25:595-603, 1976
6. Karam JH, Lewitt PA, Young CW, Nowlain RE, Frankel BJ, Fujiya H, Freedman ZR, Grodsky GM: Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 29:971-978, 1980
7. Lewitt PA: The neurotoxicity of the rat poison vacor. A clinical study of 12 cases. N Engl J Med 302:73-77, 1980
8. Gallanosa AG, Spyker DA, Curnow RT: Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor poisoning: a review. Clin Toxicol 18:441-149, 1981
9. Kenney RM, Michaels IA, Flomenbaum NE, Yu GS: Poisoning with N-3-pyridylmethyl-N'-p-nitrophenylurea (Vacor). Immunoperoxidase demonstration of β-cell destruction. Arch Pathol Lab Med 105:367-370, 1981
10. Miller LV, Stokes JD, Silpipat C: Diabetes mellitus and autonomic dysfunction after vacor rodenticide ingestion. Diabetes Care 1:73-76, 1978
11. Solimena M, De Camilli P: Coxsackieviruses and diabetes. Nature Med 1:25-26, 1995
12. Deckert FW, Moss JN, Sambuca AS, Seidel MC, Steigerwalt RB: Nutritional and drug interactions with VACOR™ rodenticide in rats. Fed Proc 36:990, 1977
13. Degli Esposti M, Ghelli A, Ratta M, Cortes D, Estornell E: Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). Biochem J 301:161-167, 1994
14. Veitch K, Hue L: Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for Parkinsonism. Mot Pharmacol 45:158-163, 1994
15. Degli Esposti M, De Vries S, Crimi M, Ghelli A, Patarnello T, Meyer A: Mitochondrial cytochrome b: evolution and structure of the protein. Biochim Biophys Acta 1143:243-271, 1993
16. Androani A, Rambaldi M, Locatelli A, Andreani F, Poglayen G, Degli Esposti M: 3-(2-thienylvinyl) indoles as potential specific inhibitors of the energy metabolism in helminthic parasites. Eur J Med Chem 27:729-734, 1992
17. Degli Esposti M, Ngo A, McMullen G, Ghelli A, Sparla F, Benelli B, Ratta M, Linnane AW: The specificity of mitochondrial complex I for ubiquinones. Biochem J 313:327-334, 1996
18. Santerre RF, Cook RA, Crisel RD, Sharp JD, Schmidt RJ, Williams DC, Wilson CP: Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic β-cells. Proc Natl Acad Sci USA 78:4339-4343, 1981
19. Di Rago JP, Perea J, Colson AM: Isolation and RNA sequence analysis of cytochrome b mutants resistant to funiculosin, a center i inhibitor of the mitochondrial ubiquinol-cytochrome c reductase in Saccharomyces cerevisiae. FEBS Lett 208:208-210, 1986
20. Tan AK, Ramsay RR, Singer TP, Miyoshi H: Comparison of the structures of the quinone-binding sites in beef heart mitochondria. J Biol Chem 268:19328-19333, 1993
21. Degli Esposti M, Crimi M, Ghelli A: Natural variation in the potency and binding sites of mitochondrial quinone-like inhibitors. Biochem Soc Trans 22:209-213, 1994
22. Yagi T: Inhibition by capsaicin of NADH-quinone oxidoreductases is correlated with the presence of energy-coupling site 1 in various organisms. Arch Biochem Biophys 281:305-311, 1990
23. Ramsay R, McKeown KA, Johnson EA, Booth RG, Singer TP: Inhibition of NADH oxidation by pyridine derivatives. Biochem Biophys Res Commun 146:53-60, 1987
24. Sayre LM, Singh MP, Arora PK, Wang F, McPeak RJ, Hoppel CL: Inhibition of mitochondrial respiration by analogues of the dopaminergic neurotoxin l-methyl-4-phenylpyridinium: structural requirements for accumulation-dependent enhanced inhibitory potency on intact mitochondria. Arch Biochem Biophys 280:274-283, 1990
25. Gluck MR, Krueger MJ, Ramsay RR, Sablin SO, Singer TP, Nicklas WJ: Characterization of the inhibitory mechanism of 4′-alkylated l-methyl-4-phenylpyridinium analogues in mitochondria and electron transport particles. J Biol Chem 269:3167-3174, 1994
26. Wilson GL, Gaines KL: Effects of the rodenticide Vacor on cultured rat pancreatic β-cells. Toxicol Appl Pharmacol 68:375-379, 1983
27. Crouch RK, Gandy SE, Kimsey G, Galbraith RA, Galbraith GM, Buse MG: The inhibition of islet Superoxide dismutase by diabetogenic drugs. Diabetes 30:235-241, 1981
28. Atkinson MA, Maclaren NK: Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92:1608-1616, 1993
29. Moller CJ, Christgau S, Williamson MR, Madsen OD, Zhan-Po N, Bock E, Baekkesov S: Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Mol Endocrinol 6:1332-1342, 1992
30. Thomas-Reetz A, Hell JW, During MJ, Walch-Solimena C, Jahn R, De Camilli P: -γ-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic β-cells. Proc Natl Acad Sci USA 90:5317-5321, 1993
31. Erecinska M, Bryla J, Michalik M, Meglasson MD, Nelson D: Energy metabolism in islets of Langerhans. Biochim Biophys Acta 1101:273-295, 1992
32. Wallace DC: Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 57:201-223, 1995
33. Luft R: The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:8731-8738, 1994
34. Welsh N, Paabo S, Welsh M: Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin. Diabetologia 34:626-631, 1991
35. Gerbitz KD, Van den Ouweland JMW, Maassen JA, Jaksh M: Mitochondrial diabetes mellitus. A review. Biochim Biophys Acta 1271:253-260, 1995
36. Singer TP, Ramsay RR: NADH-ubiquinone oxidoreductase. In Molecular Mechanisms in Bioenergetics. Ernster L, Ed. Amsterdam, Elsevier, 1992, p. 145-162